SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
-2.58%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$210M
AUM Growth
+$210M
(+5.7%)
Cap. Flow
+$16.7M
Cap. Flow
% of AUM
7.99%
Top 10 Holdings %
Top 10 Hldgs %
36.19%
Holding
76
New
21
Increased
12
Reduced
17
Closed
15
Top Buys
| 1 |
iShares Biotechnology ETF
IBB
|
$9.29M |
| 2 |
Bristol-Myers Squibb
BMY
|
$7.31M |
| 3 |
Elevance Health
ELV
|
$7.19M |
| 4 |
Gilead Sciences
GILD
|
$5.73M |
| 5 |
McKesson
MCK
|
$4.92M |
Top Sells
| 1 |
Zimmer Biomet
ZBH
|
$7.8M |
| 2 |
Amgen
AMGN
|
$7.51M |
| 3 |
Medtronic
MDT
|
$5.62M |
| 4 |
GSK
GSK
|
$5.39M |
| 5 |
Eli Lilly
LLY
|
$5.15M |
Sector Composition
| 1 | Healthcare | 83.15% |
| 2 | Financials | 3.55% |
| 3 | Industrials | 1.31% |
| 4 | Consumer Staples | 0.98% |
| 5 | Energy | 0.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Universal Health Services
UHS
$11.6B
| $3.72M | 1.78% |
+35,000
| New | +$3.72M |
|
|
GWPH
27
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $3.1M | 1.48% |
27,700
| – | – |
|
28
Henry Schein
HSIC
$8.44B
| $3.02M | 1.44% |
+19,902
| New | +$3.02M |
|
29
Vertex Pharmaceuticals
VRTX
$100B
| $2.95M | 1.41% |
40,000
-10,000
| -20% | -$737K |
|
30
Thermo Fisher Scientific
TMO
$186B
| $2.82M | 1.35% |
20,000
-10,000
| -33% | -$1.41M |
|
31
ResMed
RMD
$40.2B
| $2.79M | 1.33% |
+45,000
| New | +$2.79M |
|
|
VWR
32
DELISTED
VWR Corporation
VWR
| $2.75M | 1.31% |
+110,000
| New | +$2.75M |
|
33
Smith & Nephew
SNN
$16.3B
| $2.56M | 1.22% |
85,000
+10,000
| +13% | +$301K |
|
34
Chemed
CHE
$6.67B
| $2.41M | 1.15% |
15,000
| – | – |
|
35
Idexx Laboratories
IDXX
$51.8B
| $2.35M | 1.12% |
+20,000
| New | +$2.35M |
|
36
Dentsply Sirona
XRAY
$2.85B
| $2.31M | 1.1% |
+40,000
| New | +$2.31M |
|
|
37
Eli Lilly
LLY
$657B
| $2.21M | 1.05% |
30,000
-70,000
| -70% | -$5.15M |
|
|
WOOF
38
DELISTED
VCA Inc.
WOOF
| $2.06M | 0.98% |
+30,000
| New | +$2.06M |
|
39
Acadia Pharmaceuticals
ACAD
$4.38B
| $2.02M | 0.96% |
70,000
+4,423
| +7% | +$128K |
|
|
PRXL
40
DELISTED
Parexel International Corp
PRXL
| $1.97M | 0.94% |
+30,000
| New | +$1.97M |
|
41
Intuitive Surgical
ISRG
$170B
| $1.9M | 0.91% |
+3,000
| New | +$1.9M |
|
|
WMGI
42
DELISTED
Wright Medical Group Inc
WMGI
| $1.61M | 0.77% |
70,000
-45,000
| -39% | -$1.03M |
|
43
Hologic
HOLX
$14.9B
| $1.61M | 0.77% |
+40,000
| New | +$1.61M |
|
|
LHCG
44
DELISTED
LHC Group LLC
LHCG
| $1.6M | 0.76% |
35,000
-10,000
| -22% | -$457K |
|
45
Agilent Technologies
A
$35.7B
| $1.6M | 0.76% |
35,000
-35,000
| -50% | -$1.6M |
|
46
Edwards Lifesciences
EW
$47.8B
| $1.41M | 0.67% |
+15,000
| New | +$1.41M |
|
|
IPXL
47
DELISTED
Impax Laboratories, Inc.
IPXL
| $1.39M | 0.66% |
105,000
-25,000
| -19% | -$331K |
|
|
SAGE
48
DELISTED
Sage Therapeutics
SAGE
| $1.02M | 0.49% |
+20,000
| New | +$1.02M |
|
49
Neurocrine Biosciences
NBIX
$13.8B
| $968K | 0.46% |
25,000
+9,400
| +60% | +$364K |
|
|
BLUE
50
DELISTED
bluebird bio
BLUE
| $926K | 0.44% |
15,000
-2,669
| -15% | -$165K |
|